# Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study

**Authors:** Zhenbin Wei, Rongrong Liu, Lingling Shi, Qiaochuan Li, Lianjin Liu, Baoshi Zheng, Chunjie Qin, Hong Chen, Guyun Wang, Meiqing Wu, Gaohui Yang, Ruolin Li, Zhaoping Gan, Qi Zhou, Jing Fan, Xuemei Zhou, Yinghua Chen, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai

PMC · DOI: 10.1002/ajh.70169 · American Journal of Hematology · 2025-12-19

## Full-text entities

- **Diseases:** Thalassemia (MESH:D013789)
- **Chemicals:** Basiliximab (MESH:D000077552)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868989/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12868989/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12868989/full.md

---
Source: https://tomesphere.com/paper/PMC12868989